Women in Immunology
New for 2020, as part of our Immuno Series we are delighted to announce the Women in Immunology symposium. This session is designed to provide a platform for female speakers to share their research and experience, highlighting the ground-breaking work being completed by women in immunology.
Confirmed Speakers
Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.
The following are confirmed speakers for the 2020 Series.
Director of Preclinical Sciences and JTX-2011 Scientific Lead
Jounce Therapeutics
Chief Scientific Officer & Founder
OncoQR ML, S-TARget Therapeutics GmbH and TYG Oncology Ltd.
Head of Scientific Business Development in Immuno-Oncology and Auto-Immune Diseases
OSE Immunotherapeutics
Chief Medical Officer and President of Clinical Development, Regulatory, Drug Safety, Quality and Medical Affairs
Sorrento Therapeutics
Executive Director, Head of Early Clinical Development, Immunology
Boehringer Ingelheim
Section of Inflammation and Cardiometabolic Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
